RUSSO, Giuseppina
 Distribuzione geografica
Continente #
EU - Europa 7.511
NA - Nord America 7.012
AS - Asia 4.096
SA - Sud America 1.367
Continente sconosciuto - Info sul continente non disponibili 411
AF - Africa 124
OC - Oceania 7
Totale 20.528
Nazione #
US - Stati Uniti d'America 6.835
RU - Federazione Russa 3.853
SG - Singapore 1.701
BR - Brasile 1.174
CN - Cina 1.170
IE - Irlanda 915
SE - Svezia 803
HK - Hong Kong 478
IT - Italia 446
DE - Germania 327
FR - Francia 260
VN - Vietnam 225
PL - Polonia 212
UA - Ucraina 208
FI - Finlandia 155
GB - Regno Unito 155
IN - India 110
AR - Argentina 65
MX - Messico 64
BD - Bangladesh 61
CA - Canada 61
IQ - Iraq 53
ID - Indonesia 45
TR - Turchia 39
ZA - Sudafrica 38
EC - Ecuador 37
AT - Austria 34
BE - Belgio 33
JP - Giappone 30
ES - Italia 27
CO - Colombia 26
NL - Olanda 23
UZ - Uzbekistan 23
VE - Venezuela 22
KE - Kenya 17
MA - Marocco 16
PK - Pakistan 16
AZ - Azerbaigian 15
CL - Cile 15
MY - Malesia 15
JO - Giordania 13
PH - Filippine 12
TN - Tunisia 12
HN - Honduras 11
SA - Arabia Saudita 11
NP - Nepal 10
UY - Uruguay 10
CI - Costa d'Avorio 9
IR - Iran 9
JM - Giamaica 9
LV - Lettonia 9
CR - Costa Rica 8
DZ - Algeria 8
KZ - Kazakistan 8
PY - Paraguay 8
DO - Repubblica Dominicana 7
AL - Albania 6
IL - Israele 6
PE - Perù 6
RO - Romania 6
AU - Australia 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BY - Bielorussia 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KR - Corea 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
LB - Libano 3
LT - Lituania 3
NG - Nigeria 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 20.097
Città #
Ashburn 1.160
Moscow 1.120
Singapore 964
Dublin 913
Chandler 674
Dallas 526
Hong Kong 476
Jacksonville 420
Beijing 401
Nyköping 383
San Jose 305
Council Bluffs 228
Warsaw 208
Los Angeles 176
The Dalles 170
Princeton 166
Lauterbourg 142
Medford 142
Messina 132
Cambridge 128
Dearborn 127
Des Moines 121
Ann Arbor 110
São Paulo 97
New York 78
Munich 72
Boardman 69
Buffalo 67
Ho Chi Minh City 66
Santa Clara 61
San Mateo 55
Bremen 54
Jinan 52
Redondo Beach 52
Tianjin 52
Wilmington 50
Shenyang 46
Hanoi 43
Guangzhou 36
Belo Horizonte 34
Rio de Janeiro 32
Woodbridge 32
Brussels 31
Nuremberg 30
Turku 30
Frankfurt am Main 29
Tokyo 29
Orem 26
Seattle 26
Catania 25
Houston 25
Pune 25
Baghdad 24
Brooklyn 24
Jakarta 24
Montreal 24
Nanjing 23
Brasília 22
Dong Ket 22
Hebei 22
Tashkent 22
Curitiba 21
Haikou 21
Atlanta 20
Chicago 20
Columbus 20
Mexico City 20
Milan 19
Rome 18
Campinas 17
London 17
Johannesburg 16
Mumbai 16
Nairobi 16
Porto Alegre 16
Shanghai 16
Denver 15
Quito 15
Vienna 15
Amsterdam 14
Baku 14
Falls Church 14
Lancaster 14
Poplar 14
San Francisco 14
Zhengzhou 14
Boston 13
Chennai 13
Istanbul 13
Ningbo 13
Phoenix 13
Shenzhen 13
Amman 12
Dhaka 12
Helsinki 12
Ribeirão Preto 12
Hangzhou 11
Manchester 11
Norwalk 11
Salvador 11
Totale 11.309
Nome #
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 273
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 257
Ischemic stroke and reperfusion therapies in diabetic patients 254
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 230
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 214
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 200
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 198
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 196
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 196
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes. 192
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 190
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 188
.Frequence of FDB in a hypercholesterolemic population from east Sicily 188
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 188
Pimozide and pancreatic cancer in diabetic chorea: a case report 187
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 185
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 181
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 174
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 170
Elevata prevalenza della colonizzazione da parte di Arcobacter spp. in soggetti asintomatici con diabete di tipo 2 168
Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus. 167
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach. 164
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 161
Correlates of total homocysteine plasma concentration in type 2 diabetes 160
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 158
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 157
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 156
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 155
Genomic Variations Affecting Biological Effects of Statins 154
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 153
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 152
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 151
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 150
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 150
Association of a Common Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) Gene with Bone Phenotypes Depends on Plasma Folate Status 149
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 149
Artificial intelligence and big data in diabetes care: A position statement of the Italian association of medical diabetologists 149
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 148
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 147
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 146
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 145
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 145
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 144
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 142
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 141
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 141
Analoghi del Glucagon-like peptide-1: cosa ci riserva il futuro. 140
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 140
Livelli plasmatici di resistina e proteina C- reattiva nelle donne: ruolo del diabete di tipo 2 e della menopausa. 139
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 138
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 137
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 137
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 137
3. High-density lipoprotein as a coronary heart disease risk factor and gene mutations affecting high-density lipoprotein cholesterol levels: Results from the Framingham Heart Study 136
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 135
Atherogenic dyslipidemia and diabetic nephropathy 134
Gli Standard di Cura terzo step: incretina + metformina. 133
Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus 132
Type 2 diabetes and cardiovascular risk in women. 131
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 126
ELEVATA PREVALENZA DELLA COLONIZZAZIONE DA PARTE DI ARCOBACTER P: IN SOGGETTI ASINTOMATICI CON DIABETE DI TIPO 2. 126
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. 125
Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now? 125
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 124
Livelli di resistina nelle donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 123
Diabetic kidney disease in the elderly: Prevalence and clinical correlates 123
Livelli di omocisteina, vitamina B12 e folati in soggetti con diabete mellito di tipo 2 con o senza neuropatia diabetica. Ruolo della metformina 120
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 119
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 118
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 118
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 117
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 116
A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: the amd annals initiative 115
Inflammatory markers in women with a recent history of gestational diabetes mellitus 115
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 115
CAPTURE: a multinational,cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. 115
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 114
Necrobiosis lipoidica associated with Hashimoto's thyroiditis and positive detection of ANA and ASMA autoantibodies 113
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 113
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study. 113
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 113
IPEROMOCISTEINEMIA E RISCHIO CARDIOVASCOLARE NEL DIABETE: FANTASIA O REALTA'? 111
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis 110
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes 108
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus 108
Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study 108
POLIMORFISMO DEL GENE DELL'APOLIPOPROTEINA E E PATOLOGIA COLELITIASICA IN UNA POPOLAZIONE DEL SUD ITALIA 107
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. 107
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 107
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 106
Ruolo dell’ipercisteinemia e del genotipo C677T del gene della metilene tetraidrifolato redattasi (MTHFR) in una popolazione di diabetici di tipo 2 con e senza Sindrome Metabolica 104
LE DISLIPIDEMIE NEL PAZIENTE DIABETICO 102
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 102
Iperomocisteinemia moderata, polimorfismo MTHFR C677T e rischio di complicanze croniche nel diabete di tipo 2: uno studio prospettico 102
Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes. 102
Methotrexate Increases Skeletal Muscle GLUT4 Expression and Improves Metabolic Control in Experimental Diabetes 102
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 102
Frequence of FDP in a hypercholesterolemic population from East Sicily 101
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 101
Totale 14.421
Categoria #
all - tutte 71.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.095 0 96 10 46 34 10 88 41 25 276 123 346
2022/20232.655 193 195 137 214 205 251 25 174 1.151 19 62 29
2023/2024608 47 90 44 56 42 134 19 42 3 27 18 86
2024/20253.329 50 52 73 207 168 125 84 653 822 201 303 591
2025/20269.401 425 564 666 651 806 1.991 1.225 1.122 1.160 425 173 193
2026/2027767 216 551 0 0 0 0 0 0 0 0 0 0
Totale 20.528